Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.06
Delayed Data
As of May 26
 -0.04 / -1.29%
Today’s Change
2.85
Today|||52-Week Range
5.13
-13.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash32.5M31.7M42.5M42.5M
 
 
 
 
 
Short Term Investment Cash-30.5M-739.0K10.7M36.0K
 
 
 
 
 
Cash & Short Term Investments220.1M202.5M189.2M166.5M
 
 
 
 
 
 
ReceivablesReceivables1.1M2.3M2.4M1.9M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets7.5M4.9M4.0M5.1M
 
 
 
 
 
Current Assets228.8M209.7M195.6M173.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----33.2M--
 
 
Depreciation-----20.0M--
 
 
Intangible Assets29.3M29.0M172.5M172.2M
 
 
 
 
 
Other Assets31.1M30.9M174.6M174.2M
 
 
 
 
 
Total Assets271.2M251.9M383.4M360.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable706.0K1.0M1.7M2.7M
 
 
 
 
 
Accrued Expenses14.9M13.2M21.5M19.4M
 
 
 
 
 
Other Current Liabilities19.3M17.6M26.4M24.4M
 
 
 
 
 
Other Liabilities20.0M18.6M35.2M27.0M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities16.5M16.2M82.7M85.2M
 
 
 
 
 
Total Liabilities36.5M34.9M117.9M112.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity234.7M217.1M265.4M247.8M
 
 
 
 
 
Total Shareholder Equity234.7M217.1M265.4M247.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding99.4M101.2M120.5M124.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.